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PUVA-INDUCED UVB-TUMOR SUSCEPTIBILITY 
To the Editor: 
We were extremely interested in the recent report by Kripke, Mori-
son, and Parrish [lJ concerning short wave ultraviolet light (UVB) 
induced tumor susceptibility in mice treated with either UVB or 8-
methoxypsoralen plus UVA (PUVA). Since their results diametrically 
oppose our earlier findings [2], we felt compelled to clarify the major 
difference between the two methodologies employed. 
Previous reports from both laboratories [3, 4J have established that 
UVB-regressor (UVB') tumors, while rejected by normal syngeneic 
mice, are capable of progressive growth in UVB-treated hosts. T his 
UV-induced tumor-susceptible state is known to be mediated by antigen 
specific (Roberts et al, manuscript in preparation [5], radiosensitive, 
Ia+, suppressor T -Iymphocytes [6]. In both studies [1, 2], experiments 
were designed to determine if PUVA treatments would mimic the 
effects of UVB by rendering mice susceptible to UVB'-tumor growth. 
We reported [2] that PUVA-treated mice supported UVB'-tumor 
growth and presented evidence suggesting la+, suppressor-cell involve-
ment. In contrast, Kripke, Morison and Parrish [1] found that PUV A 
treated mice behaved like normal animals and rejected UVB' tumors. 
Although Kripke, Morison and Parrish attempted to approximate om 
experimental protocol [2], their UVA irradiations were made with 
m ylar filtered light rather than with UVA bulbs emitting their entire 
photospectrum. It is this difference between ow' two methodologies 
that accounts for the discrepancies in om results. 
In their discussion, Kripke, Morison and Parish suggest two possible 
explanations for the discrepancy between their fmdings and om·s. First, 
the a uthors 'suggest that irnmunologic debmtation due to infectious 
disease, secondary to the PUV A treatments, may have been of sufficient 
magnitude to permit tumor growth in our PUV A-treated mice. Al-
t hough we have never published the microbial or viral status of our 
animals and tumors, both have been screened (for many of the same, 
and some additional, pathogens lis ted by Kripke, Morison, and Parrish) 
and were found to be pathogen free. Thus, this contention proves 
invalid. The second possibility, which in om opinion is far more intri-
guing and received too little attention in their discussion, reiterates the 
major difference between our two protocols, i.e., the use of filtered 
versuS unfiltered UVA. In comparing our data [2] with that of Kripke, 
Morison, and Parrish [lJ it would appear that, at least for the induction 
of UVB'-twnor susceptibility, the effects mediated by PUV A may 
result from a synergism between 8-methoxypsoralen and the small 
amounts of short wave UV emitted by UV A bulbs rather than a true 
potentiation of long wave UV light (wave lengths greater than 320 nm). 
This aspect of PUVA-treatment and its effect on UVB-tumor suscep-
tibility certainly requires further investigation. 
We believe that our protocol [2] is more clinicaUy relevant than that 
employed by Kripke, Morison and Parrish [1]. To ow' knowledge it is 
the full emission spectrum of the UV A bulbs, rather than mylar filtered 
light, that is used when treating psoriasis and vitiligo patients with 
PUV A. In addition, we strongly believe that our interpretations of 
experimental results presented previously [2, 7], and t he available 
human data [8], suggest a link between cancer risk and tumor specific 
suppression induced by UVB and possibly PUV A [9]. 
Lee K. Roberts 
University of New Mexico School of Medicine 
Raymond A. Daynes 
University of Utah Medical Center 
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REPLY 
It is helpful to know that tlle animals used by Roberts, Schmitts, 
and Daynes were pathogen free and that the authors agree with one of 
our suggested explanations for the discrepancy between their findings 
and ours. It would be unwise to overstate the clinical relevance of either 
study, even though we agree the use of unftltered bulbs is common in 
clinical situations. However, the stated intention of their study was to 
investigate the effect of methoxsalen and UVA (320-400 nm) radiation. 
It would appear that by adopting the approach of using unfiltered 
bulbs, they have inadvertently investigated the effects of UVB radiation 
and even possibly an interaction between methoxsalen and UVB radia-
tion. Obviously, further studies are required to dissect out the vru'ious 
influences that they have studied. 
M. L. Kripke 
W. L. Morison 
Frederick Cancer Research Center 
J. A. Parrish 
Massachusetts General Hospital 
CIRCADIAN RHYTHMS IN MITOTIC INDEX IN NORMAL 
AND PSORIATIC EPIDERMIS 
Gelfant et al [1] in their recent report state "there are no circadian 
diurnal variations in epidermal cell proliferation" in uninvolved pso-
riatic skin. 
I believe this should be amended to state that in the 12 biopsies 
taken each time from the male psoriatic volunteers comprising their 
experimental material, they found no circadirul diurnal vru'iation in 
mitotic index in the epidermis. We, however, have reported a very 
definite diurnal variation in mitotic index of normal humrul epidermis, 
and uninvolved epidermis of psoriatics, as we reported previously '[2]' 
Oux difference may relate to sample size. 
More than by chance, and with high statistical significance [3], 
mitotic figures in adult hwnan epidermis are found clustered. This 
occW's at different sites within the same 6-mm biopsy, and from biopsy 
to biopsy taken at the same time from the buttock area of the same 
individual. To obtain a mitotic index that represents the individual in 
view of this clustering, xequires extensive sampling. 
Gelfant et al compared findings at 4 times during 24 hr. However, in 
contrast to our findings, their table 1 shows no significant difference in 
mitotic index from 9 AM to 3 PM either. 
However, we counted mitoses on 99 biospies in 33 psoriatics for 20 
cm length of epidermis (40 sections) each biopsy, at 9 AM and 99 morl! 
biopsies at 3 PM for uninolved skin of psoriatics. Gelfant's [1] sample 
size was 12 biopsies counted for 10 cm length each at 9 AM and again at 
3 PM. 
